Prostate Cancer Vaccine | search
Click here to view Prostate Cancer Vaccine news from 60+ newspapers.
Bookmark or Share- What’s new in immunotherapy for prostate cancer?One of the earliest immunotherapies approved by the Food and Drug Administration (FDA) for the treatment of cancer was a vaccine called sipuleucel-T. It’s been used to treat metastatic prostate cancer since 2010.
- Immunotherapy for Prostate CancerSipuleucel-T (Provenge®) is a cancer vaccine used to boost the immune system to get it to attack prostate cancer cells in the body. Learn more here.
- Cancer Vaccines: The Types, How They Work, and Which Cancers They TreatProstate Cancer Vaccine. Sipuleucel-T (Provenge®) is used for the treatment of people whose prostate cancer has metastasized (spread). Provenge is created by removing some immune cells, exposing them to a molecule from prostate cancer cells, and then infusing them back into the body.
- Immunotherapy for Prostate Cancer - WebMDThe Future of Immunotherapy. 5 min read. Surgery and radiation treat prostate cancer by removing or killing cancer cells. Immunotherapy is different. It trains your immune system to attack the...
- Advances in Prostate Cancer Research - NCIStudying Early Detection for Men at High Risk. Men with certain inherited genetic traits are at increased risk for developing prostate cancer. Examples of such traits include inherited BRCA gene mutations and Lynch syndrome. No clear guidelines exist for when or how—or if—to screen men at high genetic risk for prostate cancer.
More
